Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose IL-2 in Type 1 Diabetes
NCT01353833Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2011
- Primary completion
- Oct 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in type 1 diabetes mellitus (T1D), sponsored by Assistance publique - Hôpitaux de Paris. Started May 2011; status: completed.
02
Drugs
aldesleukin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01353833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01353833.